DataMeds AI (MEDS) Share-based Compensation (2024 - 2026)

DataMeds AI (MEDS) has reported Share-based Compensation for 3 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 95.11% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $28.4 million (changed N/A YoY), and the FY2025 full-year result was $54.8 million, up 255.81% from the prior year.
• Share-based Compensation rose to $1.4 million in Q1 2026 per MEDS's latest filing, from $355698.0 in the prior quarter.
• Across five years, Share-based Compensation topped out at $27.8 million in Q1 2025 and bottomed at -$403000.0 in Q3 2024.
• Historically, Share-based Compensation has averaged $10.2 million across 3 years, with a median of $1.4 million in 2026.
• The widest YoY moves for Share-based Compensation: up 6481.27% in 2025, down 97.69% in 2025.
• Over 3 years, Share-based Compensation stood at $15.4 million in 2024, then slumped by 97.69% to $355698.0 in 2025, then surged by 281.72% to $1.4 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $1.4 million, $355698.0, and $25.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.